INTRODUCTION
Methylglyoxal (MG) is a highly reactive a-oxoaldehyde formed in cells primarily from the triose phosphate intermediates of glycolysis, dihydroxyacetone phosphate and glyceraldehyde 3-phosphate (Phillips and Thornalley, 1993; Richard, 1993) . It is the major physiologic substrate for the enzyme glyoxalase I, which is encoded by the GLO1 gene. Together with glyoxalase II and a catalytic amount of GSH, glyoxalase I reduces methylglyoxal to D-lactate (Thornalley, 2003a) . In cells, methylglyoxal reacts almost exclusively with arginine residues to form the major methylglyoxal-derived epitope hydroimidazolone MG-H1 (Na-acetyl-Nd (5-hydro-5-methyl)-4-imidazolone; Ahmed and Thornalley, 2003) . Changes in methylglyoxal concentration have been implicated in the pathobiology of a variety of important diseases, including cancer, malaria, renal failure, and diabetic vascular disease (Agalou et al., 2003; Beisswenger et al., 2003; Creighton et al., 2003; Iozef et al., 2003; Sakamoto et al., 2001; Thornalley, 2003a; Thornalley, 2003b) .
Levels of hyperglycemia that cause diabetic vascular pathology increase the concentration of both methylglyoxal (Shinohara et al., 1998) and the methylglyoxal argininederived hydroimidazolone adduct MG-H1 in aortic endothelial cells , and increased retinal levels of MG-H1 in diabetic rats are associated with the formation of acellular capillaries, the major structural lesion of both human nonproliferative retinopathy and experimental diabetic retinopathy (Hammes et al., 2003) . In diabetic retinal capillaries, the earliest morphological changes are pericyte loss and acellular capillary formation. The primary pathologic processes of retinal pericyte loss and acellular capillary
Cell 124, 275-286, January 27, 2006 ª2006 Elsevier Inc. 275 formation are regulated by complex context-dependent interactions among a number of pro-and antiangiogenic factors (Carmeliet, 2003; Hanahan, 1997; Jain, 2003) , including angiopoietin-2 (Ang-2). When insufficient levels of VEGF and other angiogenic signals are present, Ang-2 causes endothelial cell death and vessel regression (Gale et al., 2002; Hackett et al., 2002; Maisonpierre et al., 1997) . Diabetes induces a significant increase in retinal expression of Ang-2 in rats (Hammes et al., 2004) , and diabetic Ang-2 +/ÿ mice have both decreased pericyte loss and reduced acellular capillary formation (Hammes et al., 2002) . The observed association between diabetes-induced increased retinal levels of MG-H1 and the formation of acellular capillaries led us to hypothesize that methylglyoxal might directly regulate transcription of genes involved in acellular capillary formation, such as Ang-2, by covalently modifying proteins that bind to the Ang-2 promoter.
In the present study, we demonstrate that in retinal Mü ller cells, the major cell type expressing angiopoietin-2 in the retina (Sarthy et al., 1998) , increased glycolytic flux causes increased methylglyoxal modification of the corepressor mSin3A. Methylglyoxal modification of mSin3A results in increased recruitment of O-GlcNAc transferase to an mSin3A-Sp3 complex, with consequent increased modification of Sp3 by O-linked N-acetylglucosamine. This modification of Sp3 causes decreased binding of the repressor complex to a glucose-responsive GC box in the angiopoietin-2 promoter, resulting in increased Ang-2 expression. This novel mechanism for regulating gene expression may play a role in the pathobiology of a variety of conditions associated with changes in methylglyoxal concentration, including cancer, malaria, renal failure, and diabetic vascular disease.
RESULTS

Ang-2 Transcription Is Induced in High-Glucose Conditions
We first examined the effect of glyoxalase I (GLO1) overexpression on high glucose-flux-induced expression of Ang-2 mRNA in retinal Mü ller cells (rMC-1). Since incubation in high glucose increases intracellular glucose flux and methylglyoxal concentration in cells damaged by hyperglycemia (Brownlee, 2001) , we first examined the effects of incubating Mü ller cells in 30 mM glucose. Under these conditions, glycolytic flux increased 2-fold (data not shown), and intracellular methylglyoxal concentration increased 1.7-fold (2.6 ± 0.1 versus 1.5 ± 0.2 pmol/million cells). This treatment increased Ang-2 mRNA level more than 3-fold compared to 5 mM glucose ( Figure 1A ). Since overproduction of superoxide by mitochondria is the major mechanism by which hyperglycemia increases intracellular levels of the glyoxalase I substrate methylglyoxal (Brownlee, 2001) , we also evaluated the effect of overexpressing either uncoupling protein-1 (UCP-1), a specific protein uncoupler of oxidative phosphorylation capable of collapsing the proton electrochemical gradient, or manganese superoxide dismutase (MnSOD), the mitochondrial form of this antioxidant enzyme. Protein levels were increased 2.7-fold for GLO1, 1.9-fold for UCP-1, and 2.3-fold for MnSOD ( Figure 1D ). Each of these normalized intracellular methylglyoxal concentration and completely prevented the hyperglycemia-induced increase of Ang-2 mRNA. Identical results were obtained for Ang-2 protein levels (Figure 1B) . GLO1 siRNA treatment of cells incubated in low glucose increased both Ang-2 transcription activity and Ang-2 protein level to that induced by high-glucose flux (data not shown).
We next examined the effect of glyoxalase I overexpression on hyperglycemia-induced expression of Ang-2 using a reporter construct containing 2.5 kb of mouse Ang-2 genomic 5 0 flanking region (ÿ2301 to +183) fused to the luciferase gene (Maisonpierre et al., 1997) . Thirty millimolar glucose treatment increased luciferase activity 2.7-fold compared to that of 5 mM glucose ( Figure 1C) . Overexpression of GLO1, UCP-1, and MnSOD each prevented hyperglycemiainduced increase of transcriptional activity. Incubating cells in medium containing 10 mM methylglyoxal for either 60 min or for 24 hr did not increase Ang-2 expression (data not shown).
Identification of a Glucose-Responsive Element in the Ang-2 Promoter To localize the regulatory elements required for transcriptional activation of the Ang-2 gene by hyperglycemia, progressive 5 0 promoter deletion constructs were generated containing different portions of the Ang-2 promoter. In 5 mM glucose, the reporter activities were not markedly different among the ÿ2301, ÿ1983, ÿ1283, ÿ993, ÿ739, and ÿ213 deletion constructs. However, a significant decrease of activity was observed in the ÿ33 construct compared to the ÿ213 construct. In 30 mM glucose, the activities were increased approximately 2.5-fold compared to those in 5 mM glucose in all constructs. With the ÿ33 construct, hyperglycemia had no effect. These data indicate that promoter elements between ÿ213 and ÿ33 are responsible for hyperglycemia-induced transcriptional activation of the Ang-2 promoter ( Figure 1E ). Comparison of these sequences with transcription factor databases (TFSEARCH) revealed two c-Ets sites (positions ÿ193 and ÿ164), an AP-1 site (ÿ173), an AP-2 site (ÿ144), and an Sp1 site (ÿ139) ( Figure 1F ).
We next explored the possible involvement of these motifs in the hyperglycemia-induced increase in transcriptional activity of the Ang-2 promoter using a series of mutated or deleted Ang-2 luciferase constructs. As shown in Figure 1F , deletion of the distal c-Ets (position ÿ193) revealed no decrease in hyperglycemia-induced transcriptional activation. Similarly, mutation of the AP-1 site (construct ÿ174 + AP-1 mut), the proximal c-Ets site (position ÿ164) or deletion of sequence upstream of nt ÿ157 (construct ÿ157) also had no effect. In contrast, mutation of the GC-rich sequences between the AP-2 and Sp1 site (ÿ174 + GC mut and ÿ164 + GC mut), and deletion of sequence upstream of nt ÿ114 each caused complete inhibition of hyperglycemia-induced activation. These data indicated that the GC-rich sequence between the AP-2 and Sp1 site is required for glucose-responsiveness of the Ang-2 promoter. 
R E T R A C T E D
Sp3 and Sp1 Binding to the Ang-2 Promoter Changes in Response to High Glucose To determine which of these nuclear proteins binds to the GC-box site and what the effects of hyperglycemia and glyoxalase I overexpression are in the context of native chromatin structure, chromosomal immunoprecipitation (ChIP) analysis was performed using antibodies specific for the indicated cognate proteins shown in Figure 2 . After immunoprecipitation and reversal of the crosslinking, the endogenous Ang-2 promoter was enriched by real-time PCR amplification using primers specific for the Ang-2 GC box site. The PCR product from Sp1 immunoprecipitation was increased 1.7-fold by 30 mM glucose compared to 5 mM glucose, and this increase was prevented by overexpression of GLO1, as well as by overexpression of UCP-1 or MnSOD ( Figure 2A ). In contrast, the PCR product from Sp3 immunoprecipitation was decreased 1.8-fold in 30 mM glucose compared to 5 mM ( Figure 2B ). This decrease was prevented by overexpression of GLO1, as well as by overexpression of UCP-1 or MnSOD. AP-2a binding was not affected ( Figure 2C ). These data indicated that Sp1, Sp3, and AP-2a bind to the Ang-2 promoter in the context of its native chromatin structure and suggested that the observed changes in Sp1 and Sp3 binding induced by incubating cells in 30 mM glucose mediated high-glucose-induced Ang-2 expression.
Sp3 Complexes with Methylglyoxal-Modified
Proteins, but Neither Sp3 nor Sp1 Is Modified by Methylglyoxal Since GLO1 overexpression prevented hyperglycemia-induced changes in Sp1 and Sp3 binding to the glucose-responsive element in the Ang-2 promoter (Figure 2 ), we hypothesized that hyperglycemia induced these changes by modifying either Sp1, Sp3, or both with methylglyoxal. To demonstrate this, we first immunoprecipitated nuclear extracts from rMC-1 cells with anti-MG antibody and immunoblotted for Sp1, Sp3, and mSin3A ( Figure 3A ). Neither hyperglycemia nor GLO1 overexpression affected Sp1 band density. In contrast, hyperglycemia increased the density of the Sp3 band, and GLO1 overexpression prevented this increase. The hyperglycemia-induced increase in Sp3 band density was also prevented by overexpression of UCP-1 and MnSOD. Surprisingly, however, when Sp1 and Sp3 were immunoprecipitated and then immunoblotted with anti-MG, neither protein was modified by MG (data not shown). These results suggested that an Sp3-associated protein was modified by methylglyoxal, rather than Sp3 itself, and that this modification might alter Sp3 binding to the Ang-2 promoter.
Methylglyoxal Modifies mSin3A, which Increases Its Association with OGT Since a variety of proteins have been reported to associate with Sp3, we performed IP Western blots for HDAC1/2, RbAp46/48, N-CoR, OGT (data not shown), and mSin3A. Only the corepressor mSin3A was modified by MG ( Figures  3A and 3B ). Cells incubated in high glucose had a 2.7-fold increase in MG modification of mSin3A. Overexpression of GLO1, as well as UCP-1 and MnSOD, prevented this increase. Cells incubated in low glucose after transfection with GLO1-RNAi showed an increase in MG modification of mSin3A similar to that observed with high glucose (see rMC-1 cells were incubated as described in Figure 1 . Soluble chromatin was prepared from rMC-1 cells, followed by immunoprecipitation with antibodies to Sp1, Sp3, and AP-2a. The DNA extracted from the respective immunoprecipitates was amplified by real-time PCR (qPCR) using primers that amplify the glucose-responsive element in the rat Ang-2 promoter. Input represents each PCR product from 2% of the preimmunoprecipitated DNA. Representative bands and qPCR results are shown for ChIP using antibodies to Sp1 (A), Sp3 (B), AP2a (C), and Input (D). Data are expressed as mean ± SEM of three independent experiments. *p < 0.01 versus LG group. Figure S1 in the Supplemental Data available with this article online). mSin3A has been reported to recruit the enzyme O-GlcNAc transferase (OGT; Yang et al., 2002) . When immunoprecipitated mSin3A was immunoblotted for OGT, cells incubated in high glucose had significantly more OGT associated with mSin3A ( Figure 3B ). Overexpression of GLO1, as well as UCP-1 and MnSOD, prevented this increase. This effect was confirmed by immunoprecipitating OGT and then immunoblotting for mSin3A ( Figure 3C ).
R E T R A C T E D
To determine which MG-modifiable residues in mSin3A were required for this increased binding of OGT, we first showed that the PAH4 domain of mSin3A was both necessary and sufficient for this methylglyoxal-responsive recruit- , and aa 955-1219) into the pVP16-AD-vector for mammalian two-hybrid assays with pM-DBD-OGT (1-286) (data not shown). These data are consistent with data reported by Yang et al. (2002) showing that the PAH4 domain of mSin3A was necessary and sufficient for binding OGT. Although methylglyoxal reacts primarily with Arg (R) residues in vivo, Lys (K) and Cys (C) residues in proteins can also be modified (Chaplen et al., 1998; Van Herreweghe et al., 2002) . We therefore evaluated the possible role of each R, K, and C residue in the PAH4 domain of mSin3A ( Figure 3D ) by making point mutants in the PAH4 domain that converted each of the 14 residues to Mammalian two-hybrid assays showed that overexpression of GLO1 completely prevented the increased association of mSin3A with OGT induced by high glucose ( Figure S2 ). Single mutations of R923, R925, and K938 partly prevented the increased association of mSin3A and OGT, and double mutation of R925 and K938 completely prevented the increased association. Double mutation of R923 and R925 was no more effective than mutation of R925 alone, and double mutation of R923 and K938 was slightly more effective than mutation of K938 alone ( Figure S2 ). These results are consistent with receptor binding domain (RBD) analysis from the PAH4 domain sequence data ( Figure S3 ), which identified six methylglyoxal-modifiable residues as potential sites critical for protein-protein interaction (R916, R923, R925, R936, R947, and K938).
The effect of the double mutation on high-glucose-induced modification of mSin3A by methylglyoxal was evaluated directly by IP:WB after overexpression of either wt or mutant mSin3A ( Figure 3E ). Incubation in high glucose caused a 2.5-fold increase in MG modification of full-length wt mSin3A. In contrast, the double mutant mSin3A/ 925+938 (Q) showed no increase in MG modification induced by incubation in high glucose. Using a two-color infrared fluorescent detection system, mSin3A and MG immunoreactivity were shown to colocalize.
Loss of functionality of the mSin3A double mutant was demonstrated by identical experiments in which the effect of high glucose on Ang-2 expression was assessed (Figure 3F) . High-glucose incubation of cells overexpressing wt mSin3A increased Ang-2 expression by 2.9-fold, while high-glucose incubation of cells overexpressing mSin3A/ 925+938 (Q) had no effect on Ang-2 expression.
Association of Sp3 with OGT Causes Sp3 Glycosylation
To directly demonstrate that increased methylglyoxal concentrations induced by high-glucose flux caused increased association of Sp3 with OGT, nuclear extracts were immunoprecipitated with anti-Sp3, and then immunoblotted for OGT and O-GlcNAc ( Figure 4A ). High glucose increased association of Sp3 with OGT and also increased modification of Sp3 by O-GlcNAc. Overexpression of GLO1, as well as UCP-1 and MnSOD, prevented both of these increases. These results were confirmed by immunoprecipitation with anti-O-GlcNAc and immunoblotting for Sp3 ( Figure 4B ).
Methylglyoxal Modification of mSin3A Decreases Sp3 and mSin3A Binding to the Ang-2 Promoter To determine whether the high-glucose-induced changes described thus far do in fact reduce binding of Sp3 and mSin3A and increase binding of Sp1 to the Ang-2 promoter GC box, we performed DNA affinity precipitation assays (DAPA). Nuclear extracts were precipitated by doublestranded nucleotides corresponding to the Ang-2 promoter GC box and immunoblotted for Sp3, mSin3A, and Sp1 (Figure 5) . High glucose reduced binding of both Sp3 and mSin3A by 2-fold but increased binding of Sp1. Overexpression of GLO1, as well as UCP-1 and MnSOD, prevented the high-glucose-induced changes in binding of these proteins to the Ang-2 promoter GC box.
Sp3 Glycosylation Causes Decreased Binding of Sp3/mSin3A/OGT Complex to the Ang-2 Promoter, and Binding Can Be Restored by Inhibiting Glycosylation To determine directly whether modification of Sp3 by OGT is critical for decreased binding of the Sp3/mSin3A complex to the Ang-2 promoter GC box, we used antisense to inhibit the rate-limiting enzyme of UDP-GlcNAc formation, glutamine: fructose-6-phosphate amidotransferase (GFAT). Inhibition of this enzyme prevents O-GlcNAc modification of proteins by OGT (Du et al., 2001; Wells and Hart, 2003) . As shown in Figure 6A , GFAT antisense, which reduced GFAT mRNA by 61%, completely prevented the increased modification of Sp3 by O-GlcNAc caused by high-glucose flux. Critical for our hypothesis, GFAT antisense also prevented both the decreased binding of Sp3 and mSin3A and the increased binding of Sp1 to the Ang-2 promoter GC box ( Figure 6B ). To further demonstrate that Sp3 glycosylation decreases its binding to the Ang-2 promoter GC box, we overexpressed Figure 6C ), and like AS-GFAT, it also prevented both the decreased binding of Sp3 and mSin3A and the increased binding of Sp1 to the Ang-2 promoter GC box ( Figure 6D ). Finally, we incubated cells in 5 mM glucose in the presence of a specific inhibitor of O-GlcNAcase, PUGNAc (Horsch et al., 1991) . PUGNAc treatment of cells incubated in 5 mM glucose increased Sp3 modification by O-GlcNAc to the same extent as high glucose ( Figure 6C ). Concomitantly, PUGNAc treatment of cells incubated in 5 mM glucose also decreased binding of Sp3 and mSin3A and increased binding of Sp1 to the Ang-2 promoter GC box to the same extent as high glucose ( Figure 6D ).
DISCUSSION
In the present study, we describe a novel mechanism for regulating gene expression: regulatory protein modification by the glycolysis-derived dicarbonyl metabolite methylglyoxal. We demonstrate that in retinal Mü ller cells, increased glycolytic flux causes increased methylglyoxal modification of the corepressor mSin3A. Methylglyoxal modification of mSin3A results in increased recruitment of O-GlcNAc transferase to an mSin3A/Sp3 complex, with consequent increased modification of Sp3 by O-linked N-acetylglucosamine. This modification of Sp3 causes decreased binding of the repressor complex to a glucose-responsive GC box in the angiopoietin-2 promoter, resulting in increased Ang-2 expression. These findings are shown schematically in Figure 7 .
The mSin3A Corepressor Is Regulated by Methylglyoxal mSin3A is a large protein with multiple protein-protein interaction domains (Kuzmichev et al., 2002; Skowyra et al., 2001) . It functions as a corepressor for a number of transcriptional repressors (Ahringer, 2000; Knoepfler and Eisenman, 1999) . The core mSin3A corepressor complex appears to involve associated histone deacetylases HDAC1/2 (Hassig et al., 1997; Laherty et al., 1997) and linking proteins (Zhang and Dufau, 2002) . Only mSin3A itself was modified by methylglyoxal in our studies. It is possible, however, that very low levels of methylglyoxal modification on other proteins may not have been detectable. Using a mammalian two-hybrid assay, we found that the mSin3A paired amphipathic helix 4 (PAH4) domain was necessary and sufficient for increased association of methylglyoxal-modified mSin3A with O-GlcNAc transferase. Within the PAH4 domain, mutation of R925 markedly impaired this increased association, while mutation of R923 or K938 had smaller effects. Double mutation of R925 and K938 completely prevented the increased association, while double mutation of R923 and R925 was no more effective than mutation of R925 alone. The arginine and lysine residues most reactive with methylglyoxal are those with proximate arginine and lysine residues that decrease the pK a of both interacting amino groups and a glutamic acid or aspartic acid carboxylate side chain on the alternate side in the sequence to act as a catalytic base (Ahmed et al., 2005; Venkatraman et al., 2001) . Assuming helical configuration of the nonproline sequences in PAH4, R925 is activated for methylglyoxal modification by the effects of both R929 and E921. The other arginine residues in PAH4 lack one or both of these activating influences-including R923 and R929, which have only basic and cationic activating groups, respectively. The modest functional effect of mutated R923 and its nonadditive effect in the double mutant R923+R925 suggest that R923 may mediate effects on PAH4-OGT binding through reorientation of R925. R923 has proximity to W927 in a helix configuration, with the formation of a strong cation-p bonding interaction (Crowley and Golovin, 2005) . Disruption of this interaction would relax the helix, which could change the orientation of R925. In the R923+R925 double mutant, this effect would be redundant. K938 has both two proximate basic and one cationic activating group, while the other two lysine residues in the PAH4 domain do not. mSin3A has been shown to recruit the enzyme OGT to promoters in a several tumor cell lines, which then acts in concert with histone deacetylation to promote gene silencing (Yang et al., 2002) . In contrast, our data in retinal Mü ller cells show that recruitment of OGT to mSin3A activates, rather than represses, gene expression, when the mSin3A is modified by methylglyoxal arising from high-glucose flux and rMC-1 cells were incubated as described in Figure 1 . Nuclear extracts were precipitated in a DAPA assay using a double-strand oligonucleotide containing the Ang-2 promoter GC box and immunoblotted (IB) with antibodies against Sp3, mSin3A, and Sp1. Ten percent of nuclear extracts were immunoblotted for b-actin as input control. The experiments were repeated three times, and the band densities were quantified by IMAGEQUANT.
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reactive oxygen species formation by the mitochondrial electron transport chain.
Regulation of Other Factors by Methylglyoxal
It has been suggested that in Saccharomyces cerevisiae, methylglyoxal reversibly modifies cysteine residues in the transcription factor Yap1, causing nuclear localization and activation (Maeta et al., 2004) . Glyoxalase I-deficient mutants showed increased Yap1 activation. However, in these experiments, no measurements of methylglyoxal-derived adducts on cellular proteins were performed. Thus, neither methylglyoxal modification of Yap1 nor modification of proteins interacting with or signaling to Yap1 was directly demonstrated. Incubation of S. cerevisiae with an 80,000-fold higher concentration of methylglyoxal than that found in Mü ller cell medium activated Yap1, but this high concentration of exogenous methylglyoxal almost certainly modified many cell surface proteins, which may have affected Yap1 activation. In our Mü ller cell experiments, incubation with 100 times the concentration of methylglyoxal found in Mü ller cell medium had no effect on Ang-2 transcription.
mSin3A Binding and Regulation of Sp3 mSin3A binding with the ubiquitous transcription factor Sp3 has not been reported previously. Sp3 and Sp1 compete for common GC-rich target sequences in promoter elements (Li et al., 2004; Suske, 1999) . Although both Sp3 and Sp1 may act as inhibitors or activators of gene expression, Sp3 has been found to repress Sp1-mediated transcriptional activation in a number of cell types (Ghayor et al., 2001; Hagen et al., 1994) . The function of Sp1 depends on promoter context, recruitment of transcription-modifying factors such as the chromatin-remodeling SWI/SNF family proteins for Sp1 transactivation (Lu et al., 2003) and a variety of posttranslational modifications (Li et al., 2004) .
Glycosylation of Transcription Factors as a General Regulatory Mechanism
Modification of nearly all RNA polymerase II-dependent transcription factors on serine and threonine residues by O-linked N-acetylglucosamine is a dynamic process, analogous to phosphorylation/dephosphorylation. The glycosylation status is regulated by the relative activities of the -b-N-acetylglucosaminidase (O-GlcNAcase; Kamemura and Hart, 2003) . O-GlcNAcylation of Sp1 may stimulate or repress transcription (Du et al., 2000; Kang et al., 2003; Roos et al., 1997; Yang et al., 2001 ), most likely depending on which residues are modified. In 293 cells and SL2 cells, Sp3 was not modified by O-GlcNAc, as determined by wheat germ agglutinin affinity chromatography (Sapetschnig et al., 2004) . However, the effect of increased glucose flux on O-GlcNAc modification of Sp3 was not evaluated. OGT has also been shown to modify the 26S, but not the 20S, proteasome, thereby reducing the processing of Sp1 (Zachara and Hart, 2004; Zhang et al., 2003) . Although the relative rates of Sp1 degradation were not evaluated in our Mü ller cell system, we found no change in total Sp1 protein levels with increased glucose flux. Methylglyoxal-modified mSin3A increases O-GlcNAcylation of Sp3 by recruiting OGT. Increased Sp3 O-GlcNAcylation decreases the binding affinity of the mSin3A/Sp3 complex to the glucose-responsive GC box in the Ang-2 promoter, allowing more Sp1 binding to the same site and resulting in increased promoter activity. This effect was replicated in cells cultured in low glucose by increasing Sp3 modification with an inhibitor of O-GlcNAcase. Similarly, this effect was inhibited in cells cultured in high glucose, by decreasing Sp3 O-GlcNAc modification with an O-GlcNAcase expression vector.
Concluding Remarks
Regulation of gene expression involves complex interactions among histones, transcription factors, coactivators, and corepressors. An emerging concept is that coactivator and corepressor proteins may be primary targets of physiologic signals, coordinating distinct biological programs . Posttranslational modifications of coactivator proteins have been described (Chakraborty et al., 2001; Fingerman and Briggs, 2004) , which are thought to regulate coactivator function. Our studies demonstrate for the first time that methylglyoxal causes posttranslational modification of a coregulator protein, which affects gene expression. The extent of this modification reflects the net effect of a variety of intracellular processes, including metabolic flux and reactive oxygen formation, and may thus function as a new integrating 
EXPERIMENTAL PROCEDURES
Promoter Constructs, siRNA, and Antisense Oligonucleotides For mapping of the glucose-responsive element of the Ang-2 promoter, the indicated deletion promoter constructs were generated by PCR methods and the indicated mutations were generated using the Site-directed Mutagenesis Kit from Promega. All constructs were verified by sequencing. GLO1 siRNA (siRNA ID, 201923) for rat was obtained from Ambion. GFAT phosphorothioate S-antisense oligonucleotides (5 0 -CCA CCT GCA AGA CCA TCG-3 0 ) and scrambled control oligonucleotides were synthesized by Operon Technologies Inc.
RT Reaction and Real-Time Quantitative PCR Total RNA from treated cells was extracted using the RNeasy Mini Kit (Qiagen), and the RNA was reverse transcribed by SuperScript III First Strand Synthesis System (Invitrogen). Real-time quantitative PCR (qPCR) was run on a Lightcycler (Roche Molecular Systems) with the LightCycler FastStart DNA Master SYBR Green I kit (Roche). Optimization of PCR was performed until the efficiency of the PCR was in the range of 0.99 1. PCR was performed by denaturing at 95ºC for 7min, followed by 45 cycles of denaturation at 95ºC, annealing at 60ºC, and extension at 72ºC for 30s, respectively. The oligonucleotide templates were diluted in the range of 10 ÿ9 10 ÿ5 mM for each standard curve. A 1:200 dilution of cDNA was used to measure 18S rRNA, and 1 ml of 1:10 dilution of each cDNA was used to measure target genes. Results were normalized by 18S rRNA.
Immunoprecipitation (IP) and Western Blotting (WB)
Cell lysates or nuclear extracts were precleared by preimmune IgG plus protein A agarose beads for 2 hr, and the supernatants were immunoprecipitated by the indicated antibodies and a 50% slurry of protein A agarose beads overnight at 4ºC (Metivier et al., 2003) . After washing with buffer containing 50 mM Tris (pH 7.5), 150 mM NaCl, 1% NP-40, and 0.5% deoxycholate with protease inhibitors, proteins were released, separated on 10% SDS-PAGE gels, and blots were developed with ECF Western Blotting Reagent Packs (Amersham). Bands were scanned by Molecular Devices STORM 860, quantified by IMAGEQUANT, and normalized to b-actin. No bands were observed after immunoprecipitation with preimmune IgG (data not shown).
Intracellular Methylglyoxal Measurement
Cellular concentrations of MG were determined by liquid chromatography-tandem mass spectrometry (LC-MS/MS) with internal standardization of [ 13 C 3 ]MG-substituted standards, as previously described, using a Micromass Quattro Ultima triple quadrupole mass spectrometric detector (Waters-Micromass; Ahmed et al., 2005) .
Chromatin Immunoprecipitation (ChIP) Chromatin was crosslinked using 1% formaldehyde for 20 min at 22ºC and terminated by addition of 0.1 M glycine. Cell lysates were sonicated and centrifuged. Five hundred micrograms protein were precleared by BSA/salmon sperm DNA plus preimmune IgG and a slurry of protein A agarose beads as previously described (Metivier et al., 2003) . Immunoprecipitations were performed with the indicated antibodies, BSA/salmon sperm DNA, and a 50% slurry of protein A agarose beads. Input and immunoprecipitates were washed and eluted, then incubated for 2 hr at 42ºC followed by 6 hr at 65ºC to reverse the formaldehyde crosslinking. DNA fragments were recovered by Proteinase K treatment followed by phenol/chloroform extraction and ethanol precipitation. A 201 bp fragment from the rat Ang-2 promoter (nt ÿ213 to nt ÿ13) was amplified by real-time PCR (qPCR). No bands were observed after immunoprecipitation with preimmune IgG (data not shown).
Two-Color Infrared Imaging of Western Blots
Cell supernatants were immunoprecipitated by the indicated primary antibodies and then simultaneously incubated with the differentially labeled species-specific secondary antibodies, anti-RABBIT IRDye 800CW (green) and anti-MOUSE ALEXA680 (red). Membranes were scanned and quantitated by the ODYSSEY Infrared Imaging System (LI-COR, NE).
DNA Affinity Precipitation Assay (DAPA)
Biotin labeled oligonucleotide 5 0 -agt ggg tga gcc agg ggg cgg agc ggc tgg ctg c-3 0 and its antisense were annealed and purified. Two hundred micrograms nuclear extracts in binding buffer (60 mM KCl, 12 mM HEPES [pH 7.9], 4 mM Tris-HCl [pH 7.5], 5% glycerol, 0.5 mM EDTA, 1 mM DTT and protease inhibitors) were precleared by 3 mg of scrambled doublestrand DNA supplemented with preequilibrated Tetralink Avidin Resin (Promega). The precleared nuclear extracts were further incubated with 2 mg of DAPA probe at 4ºC for 1 hr with gentle rotation, then 20 ml preequilibrated Tetralink Avidin Resin was added to incubate for another 1hr. Beads were pelleted and washed with buffer, then boiled for 5 min in SDS-PAGE gel loading buffer for Western blotting analysis.
Supplemental Data Supplemental Data include three figures and Supplemental Experimental
Procedures and can be found with this article online at http://www.cell. com/cgi/content/full/124/2/275/DC1/.
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